Balchem Co. (BCPC) Short Interest Down 26.0% in January

Balchem Co. (NASDAQ:BCPC) saw a large decline in short interest in January. As of January 12th, there was short interest totalling 761,680 shares, a decline of 26.0% from the December 29th total of 1,028,845 shares. Based on an average daily trading volume, of 107,746 shares, the short-interest ratio is presently 7.1 days. Approximately 2.4% of the shares of the stock are sold short.

Shares of Balchem (NASDAQ BCPC) opened at $80.84 on Monday. Balchem has a 12 month low of $71.95 and a 12 month high of $89.50. The company has a quick ratio of 1.49, a current ratio of 2.16 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $2,580.00, a price-to-earnings ratio of 40.62 and a beta of 1.10.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings data on Tuesday, November 7th. The basic materials company reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.01. Balchem had a return on equity of 14.68% and a net margin of 11.11%. The company had revenue of $150.72 million for the quarter.

The business also recently announced an annual dividend, which was paid on Friday, January 19th. Investors of record on Wednesday, December 27th were issued a $0.42 dividend. This represents a dividend yield of 0.5%. This is a boost from Balchem’s previous annual dividend of $0.38. The ex-dividend date of this dividend was Tuesday, December 26th. Balchem’s payout ratio is presently 21.11%.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of Balchem by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 2,885,217 shares of the basic materials company’s stock worth $224,210,000 after acquiring an additional 40,016 shares during the last quarter. Wasatch Advisors Inc. grew its holdings in shares of Balchem by 4.6% in the 2nd quarter. Wasatch Advisors Inc. now owns 1,153,188 shares of the basic materials company’s stock worth $89,614,000 after acquiring an additional 50,841 shares during the last quarter. State Street Corp grew its holdings in shares of Balchem by 5.2% in the 2nd quarter. State Street Corp now owns 780,131 shares of the basic materials company’s stock worth $60,619,000 after acquiring an additional 38,522 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Balchem by 0.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 727,055 shares of the basic materials company’s stock worth $59,103,000 after acquiring an additional 3,551 shares during the last quarter. Finally, Conestoga Capital Advisors LLC grew its holdings in shares of Balchem by 16.2% in the 4th quarter. Conestoga Capital Advisors LLC now owns 620,469 shares of the basic materials company’s stock worth $50,010,000 after acquiring an additional 86,575 shares during the last quarter. Institutional investors and hedge funds own 87.16% of the company’s stock.

Separately, BidaskClub downgraded Balchem from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th.

WARNING: This piece was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/01/29/balchem-co-bcpc-short-interest-down-26-0-in-january.html.

Balchem Company Profile

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply